Intuitive Surgical, Inc. (ISRG)
| Market Cap | 118.78B |
| Revenue (ttm) | 6.85B |
| Net Income (ttm) | 1.52B |
| Shares Out | 352.07M |
| EPS (ttm) | 4.25 |
| PE Ratio | 79.38 |
| Forward PE | 53.28 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,303,314 |
| Open | 337.83 |
| Previous Close | 338.39 |
| Day's Range | 336.62 - 339.26 |
| 52-Week Range | 222.65 - 358.07 |
| Beta | 1.34 |
| Analysts | Buy |
| Price Target | 333.14 (-1.25%) |
| Earnings Date | Jan 23, 2024 |
About ISRG
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core i... [Read more]
Financial Performance
In 2022, ISRG's revenue was $6.22 billion, an increase of 8.97% compared to the previous year's $5.71 billion. Earnings were $1.32 billion, a decrease of -22.43%.
Financial StatementsAnalyst Forecast
According to 23 analysts, the average rating for ISRG stock is "Buy." The 12-month stock price forecast is $333.14, which is a decrease of -1.25% from the latest price.
News
Intuitive Appoints Sreelakshmi Kolli to its Board of Directors
SUNNYVALE, Calif., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Intuitive (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced the ap...
Is Intuitive Surgical Stock A Pick After A 9% Fall In A Month Amid Mixed Q3?
Intuitive Surgical (NASDAQ: ISRG) recently reported its Q3 results, with revenues lower but earnings beating our estimates.
The Value Deepens for Medtech Stocks: Reversal Imminent
Results from Johnson & Johnson NYSE: JNJ and Abbott Laboratories NYSE: ABT foreshadow good news for MedTech investors. Both companies outperformed on the top and bottom lines, driven by broad strength...
Intuitive Surgical Sees Robot Procedures Slow. Blame Wegovy and Ozempic for Now.
Intuitive's bariatric surgeries have slowed due to weight-loss drugs, but the company doesn't see a lasting effect.
Medical device makers see limited hit from weight-loss drugs
U.S. medical device makers do not see a big impact of new weight-loss treatments on the sales of equipment used in procedures such as bariatric surgery due to the prohibitive costs of the drugs as wel...
Intuitive Surgical, WD-40, CSX Corp.: After-hours movers October 19, 2023
Intuitive Surgical (ISRG) shares are trading in the red in extended hours after the company's third-quarter revenue missed expectations. WD-40 Company (WDFC) shares are lower in after-hours trading as...
Intuitive Surgical misses sales estimates, shares slump
Surgical robots maker Intuitive Surgical missed analysts' estimates for third-quarter sales on Thursday, sending its shares down nearly 8% after the bell.
Intuitive Surgical's stock drops as revenue misses Street view
Intuitive Surgical Inc. ISRG, -0.75% shares fell in the extended session Thursday after the surgical robotics company's quarterly revenue missed Wall Street estimates. Intuitive Surgical shares fell a...
Intuitive Announces Third Quarter Earnings
SUNNYVALE, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today ...
Procedure Volume Growth To Drive Intuitive Surgical's Q3
Earnings are likely to come in at about $1.42 on a per-share and adjusted basis, in line with the consensus estimate of $1.41.
Jim Cramer is weighing out the risks of weight loss drugs
'Mad Money' host Jim Cramer takes a deep dive into the impact of obesity drugs on various sectors.
What other industries could weight loss drugs disrupt?
Jared Holz, Mizuho health care sector strategist, joins the ‘Fast Money' traders to discuss Novo Nordisj's kidney trial outcomes and the impact of weight loss drugs on the health care sector.
Dialysis company shares plunge after Ozempic trial success vs. kidney trouble
The trial success of Novo Nordisk's hit drug against kidney failure sent shares of a German kidney dialysis services firm plummeting on Wednesday.
With 2x Potential Returns Is DexCom A Better Pick Over Intuitive Surgical?
We believe DexCom stock (NASDAQ: DXCM) is a better healthcare pick than Intuitive Surgical stock (NASDAQ: ISRG).
A Significant Reversal is in Sight for These 5 Med Tech Companies
Med tech has been on the skids for no fault of its own. It's not the industry's fault that price action was driven to a frothy bubble by COVID-inspired trading outlooks or that the market has normaliz...
3 Most Expensive Wide-Moat Stocks to Avoid
We like these high-quality companies but we think their stocks are overvalued.
Stocks This Week: Buy Intuit And Sell Short Intuitive Surgical
Over the near term, the indices are likely to move higher, but an autumn correction looms. Here are a pair of stock recommendations, one long and one short.
ISRG Stock Sinks After Strong Earnings: Is the Growth Priced In?
Timing is everything. Intuitive Surgical, Inc. NASDAQ: ISRG delighted investors by beating revenue and earnings expectations when it reported second-quarter earnings after the market closed on July 20...
Intuitive Surgical beats profit, revenue estimates
Intuitive Surgical Inc beat Wall Street estimates for quarterly sales and profit on Thursday, boosted by a rise in total procedures volume of its surgical robot da Vinci.
Intuitive Surgical's stock falls on earnings miss
Intuitive Surgical Inc.'s ISRG, -0.58% stock tumbled 6% in extended trading Thursday after the health care giant reported quarterly earnings that came up short of analysts' estimates. Intuitive Surgic...
Intuitive Announces Second Quarter Earnings
SUNNYVALE, Calif., July 20, 2023 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today ...